Navigation Links
Combination Therapy With ENBREL And Methotrexate Found Effective In RA Treatment

Combination therapy with anti-TNF agents (etanercept) and chemotherapy drug methotrexate has been shown to be effective in the treatment of Rheumatoid Arthritis.// Furthermore, the progression of joint damage has been considerably slowed down in over three quarters of patients. The chronic nature of the severe disabling condition necessitates the need for prevention of long-term joint damage in addition to conventional treatment measures.

ENBREL is the only soluble tumor necrosis factor (TNF) receptor approved to reduce signs and symptoms, induce major clinical response, improve physical function, and inhibit the progression of structural damage in patients with moderately to severely active rheumatoid arthritis (RA). ENBREL can be used alone or in combination with methotrexate.

Tumor necrosis factor (TNF) is a substance that is produced by the immune system. People with different forms of arthritis such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis have elevated levels of TNF in their body. The drug ENBREL is designed to block the effect of TNF, thereby enabling treatment.

The drug combination was found to be superior when compared to either of the monotherapy forms. A comparison of the combination therapy, ENBREL monotherapy and methotrexate monotherapy revealed that ENBREL monotherapy had significant results when compared to monotherapy with methotrexate alone.

In addition, the improvement in physical function was significantly higher in the ENBREL combination group than for either therapy alone. The improvement in the health status was 56% in the group of patients treated with combination in comparison to 37 % mean improvement in patients treated with ENBREL alone and 33 % mean improvement in patients treated with methotrexate alone.

Nearly 686 patients were taken up for the study and were randomized into the three categories. Patients received either ENBREL (25 mg twice weekly), methotrexate (up to 20 mg once weekly), or ENBREL (25 mg twice weekly) plus methotrexate once weekly. The patients were assessed radiologically to determine the extent of joint damage. Changes in total erosions, changes in total joint space narrowing, numbers of eroded joints were amongst the various factors assessed. A considerable improvement was noted in the combination group. The tolerability was also much higher.

With more and more studies revealing the different options available for rheumatoid arthritis, choosing the right treatment is simply left to the clinical condition of the patient and the physician’s opinion.
'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... Malvern, PA (PRWEB) , ... March 23, 2017 ... ... a comprehensive educational training program owned and organized by HMP Communications Holdings, LLC, ... training program for physicians within its nationwide network of wound centers interested in ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... families and businesses of the greater Fort Collins area, has unveiled a collaboration ... ongoing community involvement program. Donations to this worthy cause may now be made ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... After raising ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established ... of its wildly popular travel innovation to Americans. , “We’re excited to be operating ...
(Date:3/23/2017)... ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital and Health System Executive ... Healthcare: Susan Salka , 43rd President of the United States of America: George ... Life In and Out of the Ring: Sugar Ray Leonard , JD, Chairperson, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Sharon Kleyne, host of the nationally syndicated ... Health on VoiceAmerica, recently talked on her program about how she is looking forward ... remind listeners of an important distinction. World Water Day, Kleyne pointed out, is an ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that it has acquired Agalimmune Ltd., a private UK-based ... of a $6 million upfront payment, of which $3 million ... future payments may be made based on development and commercial ... ...
(Date:3/23/2017)... , March 23, 2017 Pre-market today, ... Allergan PLC (NYSE: AGN), Horizon Pharma PLC (NASDAQ: HZNP), and ... Drugs stocks are part of the Healthcare sector, which was ... , 2017, with the NYSE Health Care Index adding about ... the S&P 500 also were up nearly 0.1% as a ...
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - Medicure Inc. ... Canadian specialty pharmaceutical company, is pleased to announce ... final approval from the U.S. Food and Drug ... application ("ANDA") for tetrabenazine tablets in the 12.5 ... product is a generic equivalent of the branded ...
Breaking Medicine Technology: